nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—SLC22A7—Methotrexate—testicular cancer	0.168	0.491	CbGbCtD
Ganciclovir—SLC22A8—Methotrexate—testicular cancer	0.103	0.3	CbGbCtD
Ganciclovir—SLC22A6—Methotrexate—testicular cancer	0.0715	0.209	CbGbCtD
Ganciclovir—Visual impairment—Methotrexate—testicular cancer	0.000298	0.000453	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000296	0.00045	CcSEcCtD
Ganciclovir—Vomiting—Ifosfamide—testicular cancer	0.000295	0.000449	CcSEcCtD
Ganciclovir—Hypersensitivity—Cisplatin—testicular cancer	0.000295	0.000449	CcSEcCtD
Ganciclovir—Renal failure—Doxorubicin—testicular cancer	0.000293	0.000446	CcSEcCtD
Ganciclovir—Rash—Ifosfamide—testicular cancer	0.000293	0.000446	CcSEcCtD
Ganciclovir—Dermatitis—Ifosfamide—testicular cancer	0.000293	0.000445	CcSEcCtD
Ganciclovir—Erythema multiforme—Methotrexate—testicular cancer	0.000293	0.000445	CcSEcCtD
Ganciclovir—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000293	0.000445	CcSEcCtD
Ganciclovir—Urticaria—Etoposide—testicular cancer	0.000292	0.000443	CcSEcCtD
Ganciclovir—Haemoglobin—Epirubicin—testicular cancer	0.000291	0.000443	CcSEcCtD
Ganciclovir—Jaundice—Doxorubicin—testicular cancer	0.000291	0.000442	CcSEcCtD
Ganciclovir—Stomatitis—Doxorubicin—testicular cancer	0.000291	0.000442	CcSEcCtD
Ganciclovir—Rhinitis—Epirubicin—testicular cancer	0.00029	0.000441	CcSEcCtD
Ganciclovir—Abdominal pain—Etoposide—testicular cancer	0.00029	0.000441	CcSEcCtD
Ganciclovir—Body temperature increased—Etoposide—testicular cancer	0.00029	0.000441	CcSEcCtD
Ganciclovir—Conjunctivitis—Doxorubicin—testicular cancer	0.00029	0.000441	CcSEcCtD
Ganciclovir—Urinary tract infection—Doxorubicin—testicular cancer	0.00029	0.000441	CcSEcCtD
Ganciclovir—Hepatitis—Epirubicin—testicular cancer	0.00029	0.00044	CcSEcCtD
Ganciclovir—Haemorrhage—Epirubicin—testicular cancer	0.00029	0.00044	CcSEcCtD
Ganciclovir—Tinnitus—Methotrexate—testicular cancer	0.000289	0.000439	CcSEcCtD
Ganciclovir—Hypoaesthesia—Epirubicin—testicular cancer	0.000288	0.000438	CcSEcCtD
Ganciclovir—Asthenia—Cisplatin—testicular cancer	0.000287	0.000437	CcSEcCtD
Ganciclovir—Pharyngitis—Epirubicin—testicular cancer	0.000287	0.000437	CcSEcCtD
Ganciclovir—Sweating—Doxorubicin—testicular cancer	0.000286	0.000435	CcSEcCtD
Ganciclovir—Urinary tract disorder—Epirubicin—testicular cancer	0.000286	0.000435	CcSEcCtD
Ganciclovir—Oedema peripheral—Epirubicin—testicular cancer	0.000285	0.000434	CcSEcCtD
Ganciclovir—Haematuria—Doxorubicin—testicular cancer	0.000285	0.000433	CcSEcCtD
Ganciclovir—Connective tissue disorder—Epirubicin—testicular cancer	0.000285	0.000433	CcSEcCtD
Ganciclovir—Urethral disorder—Epirubicin—testicular cancer	0.000284	0.000432	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000282	0.000429	CcSEcCtD
Ganciclovir—Angiopathy—Methotrexate—testicular cancer	0.000281	0.000427	CcSEcCtD
Ganciclovir—Visual impairment—Epirubicin—testicular cancer	0.000279	0.000424	CcSEcCtD
Ganciclovir—Mediastinal disorder—Methotrexate—testicular cancer	0.000279	0.000424	CcSEcCtD
Ganciclovir—Agranulocytosis—Doxorubicin—testicular cancer	0.000279	0.000424	CcSEcCtD
Ganciclovir—Chills—Methotrexate—testicular cancer	0.000278	0.000422	CcSEcCtD
Ganciclovir—Nausea—Ifosfamide—testicular cancer	0.000276	0.00042	CcSEcCtD
Ganciclovir—Diarrhoea—Cisplatin—testicular cancer	0.000274	0.000417	CcSEcCtD
Ganciclovir—Erythema multiforme—Epirubicin—testicular cancer	0.000274	0.000416	CcSEcCtD
Ganciclovir—Alopecia—Methotrexate—testicular cancer	0.000273	0.000416	CcSEcCtD
Ganciclovir—Mental disorder—Methotrexate—testicular cancer	0.000271	0.000412	CcSEcCtD
Ganciclovir—Hypersensitivity—Etoposide—testicular cancer	0.00027	0.000411	CcSEcCtD
Ganciclovir—Tinnitus—Epirubicin—testicular cancer	0.00027	0.000411	CcSEcCtD
Ganciclovir—Malnutrition—Methotrexate—testicular cancer	0.000269	0.00041	CcSEcCtD
Ganciclovir—Haemoglobin—Doxorubicin—testicular cancer	0.000269	0.00041	CcSEcCtD
Ganciclovir—Rhinitis—Doxorubicin—testicular cancer	0.000269	0.000408	CcSEcCtD
Ganciclovir—Haemorrhage—Doxorubicin—testicular cancer	0.000268	0.000407	CcSEcCtD
Ganciclovir—Hepatitis—Doxorubicin—testicular cancer	0.000268	0.000407	CcSEcCtD
Ganciclovir—Hypoaesthesia—Doxorubicin—testicular cancer	0.000267	0.000405	CcSEcCtD
Ganciclovir—Pharyngitis—Doxorubicin—testicular cancer	0.000266	0.000404	CcSEcCtD
Ganciclovir—Urinary tract disorder—Doxorubicin—testicular cancer	0.000265	0.000402	CcSEcCtD
Ganciclovir—Oedema peripheral—Doxorubicin—testicular cancer	0.000264	0.000401	CcSEcCtD
Ganciclovir—Dysgeusia—Methotrexate—testicular cancer	0.000264	0.000401	CcSEcCtD
Ganciclovir—Asthenia—Etoposide—testicular cancer	0.000263	0.0004	CcSEcCtD
Ganciclovir—Connective tissue disorder—Doxorubicin—testicular cancer	0.000263	0.0004	CcSEcCtD
Ganciclovir—Angiopathy—Epirubicin—testicular cancer	0.000263	0.0004	CcSEcCtD
Ganciclovir—Urethral disorder—Doxorubicin—testicular cancer	0.000263	0.000399	CcSEcCtD
Ganciclovir—Mediastinal disorder—Epirubicin—testicular cancer	0.000261	0.000397	CcSEcCtD
Ganciclovir—Back pain—Methotrexate—testicular cancer	0.000261	0.000396	CcSEcCtD
Ganciclovir—Chills—Epirubicin—testicular cancer	0.00026	0.000395	CcSEcCtD
Ganciclovir—Pruritus—Etoposide—testicular cancer	0.00026	0.000395	CcSEcCtD
Ganciclovir—Arrhythmia—Epirubicin—testicular cancer	0.000259	0.000393	CcSEcCtD
Ganciclovir—Visual impairment—Doxorubicin—testicular cancer	0.000258	0.000393	CcSEcCtD
Ganciclovir—Alopecia—Epirubicin—testicular cancer	0.000256	0.000389	CcSEcCtD
Ganciclovir—Vomiting—Cisplatin—testicular cancer	0.000255	0.000387	CcSEcCtD
Ganciclovir—Vision blurred—Methotrexate—testicular cancer	0.000254	0.000386	CcSEcCtD
Ganciclovir—Mental disorder—Epirubicin—testicular cancer	0.000254	0.000386	CcSEcCtD
Ganciclovir—Erythema multiforme—Doxorubicin—testicular cancer	0.000253	0.000385	CcSEcCtD
Ganciclovir—Rash—Cisplatin—testicular cancer	0.000253	0.000384	CcSEcCtD
Ganciclovir—Dermatitis—Cisplatin—testicular cancer	0.000252	0.000384	CcSEcCtD
Ganciclovir—Malnutrition—Epirubicin—testicular cancer	0.000252	0.000383	CcSEcCtD
Ganciclovir—Diarrhoea—Etoposide—testicular cancer	0.000251	0.000382	CcSEcCtD
Ganciclovir—Ill-defined disorder—Methotrexate—testicular cancer	0.00025	0.00038	CcSEcCtD
Ganciclovir—Tinnitus—Doxorubicin—testicular cancer	0.00025	0.00038	CcSEcCtD
Ganciclovir—Anaemia—Methotrexate—testicular cancer	0.000249	0.000379	CcSEcCtD
Ganciclovir—Flatulence—Epirubicin—testicular cancer	0.000248	0.000378	CcSEcCtD
Ganciclovir—Tension—Epirubicin—testicular cancer	0.000247	0.000376	CcSEcCtD
Ganciclovir—Dysgeusia—Epirubicin—testicular cancer	0.000247	0.000375	CcSEcCtD
Ganciclovir—Nervousness—Epirubicin—testicular cancer	0.000245	0.000372	CcSEcCtD
Ganciclovir—Back pain—Epirubicin—testicular cancer	0.000244	0.000371	CcSEcCtD
Ganciclovir—Angiopathy—Doxorubicin—testicular cancer	0.000243	0.00037	CcSEcCtD
Ganciclovir—Malaise—Methotrexate—testicular cancer	0.000243	0.000369	CcSEcCtD
Ganciclovir—Dizziness—Etoposide—testicular cancer	0.000243	0.000369	CcSEcCtD
Ganciclovir—Muscle spasms—Epirubicin—testicular cancer	0.000242	0.000369	CcSEcCtD
Ganciclovir—Vertigo—Methotrexate—testicular cancer	0.000242	0.000368	CcSEcCtD
Ganciclovir—Mediastinal disorder—Doxorubicin—testicular cancer	0.000241	0.000367	CcSEcCtD
Ganciclovir—Leukopenia—Methotrexate—testicular cancer	0.000241	0.000367	CcSEcCtD
Ganciclovir—Chills—Doxorubicin—testicular cancer	0.00024	0.000366	CcSEcCtD
Ganciclovir—Arrhythmia—Doxorubicin—testicular cancer	0.000239	0.000364	CcSEcCtD
Ganciclovir—Nausea—Cisplatin—testicular cancer	0.000238	0.000362	CcSEcCtD
Ganciclovir—Vision blurred—Epirubicin—testicular cancer	0.000238	0.000361	CcSEcCtD
Ganciclovir—Alopecia—Doxorubicin—testicular cancer	0.000237	0.00036	CcSEcCtD
Ganciclovir—Cough—Methotrexate—testicular cancer	0.000235	0.000357	CcSEcCtD
Ganciclovir—Mental disorder—Doxorubicin—testicular cancer	0.000235	0.000357	CcSEcCtD
Ganciclovir—Ill-defined disorder—Epirubicin—testicular cancer	0.000234	0.000356	CcSEcCtD
Ganciclovir—Convulsion—Methotrexate—testicular cancer	0.000233	0.000355	CcSEcCtD
Ganciclovir—Vomiting—Etoposide—testicular cancer	0.000233	0.000355	CcSEcCtD
Ganciclovir—Malnutrition—Doxorubicin—testicular cancer	0.000233	0.000355	CcSEcCtD
Ganciclovir—Anaemia—Epirubicin—testicular cancer	0.000233	0.000354	CcSEcCtD
Ganciclovir—Agitation—Epirubicin—testicular cancer	0.000232	0.000352	CcSEcCtD
Ganciclovir—Rash—Etoposide—testicular cancer	0.000231	0.000352	CcSEcCtD
Ganciclovir—Dermatitis—Etoposide—testicular cancer	0.000231	0.000352	CcSEcCtD
Ganciclovir—Headache—Etoposide—testicular cancer	0.00023	0.00035	CcSEcCtD
Ganciclovir—Flatulence—Doxorubicin—testicular cancer	0.00023	0.00035	CcSEcCtD
Ganciclovir—Arthralgia—Methotrexate—testicular cancer	0.000229	0.000349	CcSEcCtD
Ganciclovir—Myalgia—Methotrexate—testicular cancer	0.000229	0.000349	CcSEcCtD
Ganciclovir—Chest pain—Methotrexate—testicular cancer	0.000229	0.000349	CcSEcCtD
Ganciclovir—Tension—Doxorubicin—testicular cancer	0.000229	0.000348	CcSEcCtD
Ganciclovir—Dysgeusia—Doxorubicin—testicular cancer	0.000228	0.000347	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000228	0.000346	CcSEcCtD
Ganciclovir—Malaise—Epirubicin—testicular cancer	0.000227	0.000346	CcSEcCtD
Ganciclovir—Discomfort—Methotrexate—testicular cancer	0.000227	0.000345	CcSEcCtD
Ganciclovir—Nervousness—Doxorubicin—testicular cancer	0.000227	0.000344	CcSEcCtD
Ganciclovir—Vertigo—Epirubicin—testicular cancer	0.000226	0.000344	CcSEcCtD
Ganciclovir—Leukopenia—Epirubicin—testicular cancer	0.000226	0.000343	CcSEcCtD
Ganciclovir—Back pain—Doxorubicin—testicular cancer	0.000226	0.000343	CcSEcCtD
Ganciclovir—Muscle spasms—Doxorubicin—testicular cancer	0.000224	0.000341	CcSEcCtD
Ganciclovir—Confusional state—Methotrexate—testicular cancer	0.000222	0.000337	CcSEcCtD
Ganciclovir—Cough—Epirubicin—testicular cancer	0.00022	0.000335	CcSEcCtD
Ganciclovir—Anaphylactic shock—Methotrexate—testicular cancer	0.00022	0.000334	CcSEcCtD
Ganciclovir—Vision blurred—Doxorubicin—testicular cancer	0.00022	0.000334	CcSEcCtD
Ganciclovir—Convulsion—Epirubicin—testicular cancer	0.000218	0.000332	CcSEcCtD
Ganciclovir—Infection—Methotrexate—testicular cancer	0.000218	0.000332	CcSEcCtD
Ganciclovir—Nausea—Etoposide—testicular cancer	0.000218	0.000332	CcSEcCtD
Ganciclovir—Hypertension—Epirubicin—testicular cancer	0.000218	0.000331	CcSEcCtD
Ganciclovir—Ill-defined disorder—Doxorubicin—testicular cancer	0.000216	0.000329	CcSEcCtD
Ganciclovir—Anaemia—Doxorubicin—testicular cancer	0.000216	0.000328	CcSEcCtD
Ganciclovir—Thrombocytopenia—Methotrexate—testicular cancer	0.000215	0.000327	CcSEcCtD
Ganciclovir—Chest pain—Epirubicin—testicular cancer	0.000215	0.000326	CcSEcCtD
Ganciclovir—Myalgia—Epirubicin—testicular cancer	0.000215	0.000326	CcSEcCtD
Ganciclovir—Arthralgia—Epirubicin—testicular cancer	0.000215	0.000326	CcSEcCtD
Ganciclovir—Agitation—Doxorubicin—testicular cancer	0.000214	0.000326	CcSEcCtD
Ganciclovir—Anxiety—Epirubicin—testicular cancer	0.000214	0.000325	CcSEcCtD
Ganciclovir—Skin disorder—Methotrexate—testicular cancer	0.000214	0.000325	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000213	0.000324	CcSEcCtD
Ganciclovir—Hyperhidrosis—Methotrexate—testicular cancer	0.000213	0.000323	CcSEcCtD
Ganciclovir—Discomfort—Epirubicin—testicular cancer	0.000212	0.000322	CcSEcCtD
Ganciclovir—Malaise—Doxorubicin—testicular cancer	0.00021	0.00032	CcSEcCtD
Ganciclovir—Dry mouth—Epirubicin—testicular cancer	0.00021	0.000319	CcSEcCtD
Ganciclovir—Vertigo—Doxorubicin—testicular cancer	0.00021	0.000319	CcSEcCtD
Ganciclovir—Anorexia—Methotrexate—testicular cancer	0.00021	0.000319	CcSEcCtD
Ganciclovir—Leukopenia—Doxorubicin—testicular cancer	0.000209	0.000317	CcSEcCtD
Ganciclovir—Confusional state—Epirubicin—testicular cancer	0.000207	0.000315	CcSEcCtD
Ganciclovir—Anaphylactic shock—Epirubicin—testicular cancer	0.000206	0.000313	CcSEcCtD
Ganciclovir—Oedema—Epirubicin—testicular cancer	0.000206	0.000313	CcSEcCtD
Ganciclovir—Hypotension—Methotrexate—testicular cancer	0.000205	0.000312	CcSEcCtD
Ganciclovir—Infection—Epirubicin—testicular cancer	0.000204	0.000311	CcSEcCtD
Ganciclovir—Cough—Doxorubicin—testicular cancer	0.000204	0.00031	CcSEcCtD
Ganciclovir—Convulsion—Doxorubicin—testicular cancer	0.000202	0.000307	CcSEcCtD
Ganciclovir—Thrombocytopenia—Epirubicin—testicular cancer	0.000201	0.000306	CcSEcCtD
Ganciclovir—Hypertension—Doxorubicin—testicular cancer	0.000201	0.000306	CcSEcCtD
Ganciclovir—Tachycardia—Epirubicin—testicular cancer	0.000201	0.000305	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.0002	0.000305	CcSEcCtD
Ganciclovir—Skin disorder—Epirubicin—testicular cancer	0.0002	0.000304	CcSEcCtD
Ganciclovir—Hyperhidrosis—Epirubicin—testicular cancer	0.000199	0.000302	CcSEcCtD
Ganciclovir—Insomnia—Methotrexate—testicular cancer	0.000199	0.000302	CcSEcCtD
Ganciclovir—Chest pain—Doxorubicin—testicular cancer	0.000199	0.000302	CcSEcCtD
Ganciclovir—Myalgia—Doxorubicin—testicular cancer	0.000199	0.000302	CcSEcCtD
Ganciclovir—Arthralgia—Doxorubicin—testicular cancer	0.000199	0.000302	CcSEcCtD
Ganciclovir—Anxiety—Doxorubicin—testicular cancer	0.000198	0.000301	CcSEcCtD
Ganciclovir—Paraesthesia—Methotrexate—testicular cancer	0.000197	0.0003	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000197	0.0003	CcSEcCtD
Ganciclovir—Discomfort—Doxorubicin—testicular cancer	0.000196	0.000298	CcSEcCtD
Ganciclovir—Anorexia—Epirubicin—testicular cancer	0.000196	0.000298	CcSEcCtD
Ganciclovir—Dyspnoea—Methotrexate—testicular cancer	0.000196	0.000298	CcSEcCtD
Ganciclovir—Somnolence—Methotrexate—testicular cancer	0.000195	0.000297	CcSEcCtD
Ganciclovir—Dry mouth—Doxorubicin—testicular cancer	0.000194	0.000295	CcSEcCtD
Ganciclovir—Dyspepsia—Methotrexate—testicular cancer	0.000194	0.000294	CcSEcCtD
Ganciclovir—Hypotension—Epirubicin—testicular cancer	0.000192	0.000292	CcSEcCtD
Ganciclovir—Confusional state—Doxorubicin—testicular cancer	0.000192	0.000292	CcSEcCtD
Ganciclovir—Decreased appetite—Methotrexate—testicular cancer	0.000191	0.000291	CcSEcCtD
Ganciclovir—Anaphylactic shock—Doxorubicin—testicular cancer	0.00019	0.000289	CcSEcCtD
Ganciclovir—Oedema—Doxorubicin—testicular cancer	0.00019	0.000289	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00019	0.000289	CcSEcCtD
Ganciclovir—Fatigue—Methotrexate—testicular cancer	0.00019	0.000288	CcSEcCtD
Ganciclovir—Infection—Doxorubicin—testicular cancer	0.000189	0.000288	CcSEcCtD
Ganciclovir—Pain—Methotrexate—testicular cancer	0.000188	0.000286	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000187	0.000285	CcSEcCtD
Ganciclovir—Thrombocytopenia—Doxorubicin—testicular cancer	0.000186	0.000283	CcSEcCtD
Ganciclovir—Insomnia—Epirubicin—testicular cancer	0.000186	0.000283	CcSEcCtD
Ganciclovir—Tachycardia—Doxorubicin—testicular cancer	0.000186	0.000283	CcSEcCtD
Ganciclovir—Skin disorder—Doxorubicin—testicular cancer	0.000185	0.000281	CcSEcCtD
Ganciclovir—Paraesthesia—Epirubicin—testicular cancer	0.000185	0.000281	CcSEcCtD
Ganciclovir—Hyperhidrosis—Doxorubicin—testicular cancer	0.000184	0.00028	CcSEcCtD
Ganciclovir—Dyspnoea—Epirubicin—testicular cancer	0.000183	0.000279	CcSEcCtD
Ganciclovir—Somnolence—Epirubicin—testicular cancer	0.000183	0.000278	CcSEcCtD
Ganciclovir—Anorexia—Doxorubicin—testicular cancer	0.000181	0.000276	CcSEcCtD
Ganciclovir—Feeling abnormal—Methotrexate—testicular cancer	0.000181	0.000275	CcSEcCtD
Ganciclovir—Dyspepsia—Epirubicin—testicular cancer	0.000181	0.000275	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Methotrexate—testicular cancer	0.00018	0.000273	CcSEcCtD
Ganciclovir—Decreased appetite—Epirubicin—testicular cancer	0.000179	0.000272	CcSEcCtD
Ganciclovir—Hypotension—Doxorubicin—testicular cancer	0.000178	0.00027	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000178	0.00027	CcSEcCtD
Ganciclovir—Fatigue—Epirubicin—testicular cancer	0.000177	0.00027	CcSEcCtD
Ganciclovir—Pain—Epirubicin—testicular cancer	0.000176	0.000268	CcSEcCtD
Ganciclovir—Constipation—Epirubicin—testicular cancer	0.000176	0.000268	CcSEcCtD
Ganciclovir—Urticaria—Methotrexate—testicular cancer	0.000175	0.000266	CcSEcCtD
Ganciclovir—Abdominal pain—Methotrexate—testicular cancer	0.000174	0.000264	CcSEcCtD
Ganciclovir—Body temperature increased—Methotrexate—testicular cancer	0.000174	0.000264	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000173	0.000264	CcSEcCtD
Ganciclovir—Insomnia—Doxorubicin—testicular cancer	0.000172	0.000262	CcSEcCtD
Ganciclovir—Paraesthesia—Doxorubicin—testicular cancer	0.000171	0.00026	CcSEcCtD
Ganciclovir—Dyspnoea—Doxorubicin—testicular cancer	0.00017	0.000258	CcSEcCtD
Ganciclovir—Feeling abnormal—Epirubicin—testicular cancer	0.00017	0.000258	CcSEcCtD
Ganciclovir—Somnolence—Doxorubicin—testicular cancer	0.000169	0.000257	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Epirubicin—testicular cancer	0.000168	0.000256	CcSEcCtD
Ganciclovir—Dyspepsia—Doxorubicin—testicular cancer	0.000168	0.000255	CcSEcCtD
Ganciclovir—Decreased appetite—Doxorubicin—testicular cancer	0.000165	0.000252	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000164	0.00025	CcSEcCtD
Ganciclovir—Fatigue—Doxorubicin—testicular cancer	0.000164	0.00025	CcSEcCtD
Ganciclovir—Urticaria—Epirubicin—testicular cancer	0.000163	0.000249	CcSEcCtD
Ganciclovir—Pain—Doxorubicin—testicular cancer	0.000163	0.000248	CcSEcCtD
Ganciclovir—Constipation—Doxorubicin—testicular cancer	0.000163	0.000248	CcSEcCtD
Ganciclovir—Abdominal pain—Epirubicin—testicular cancer	0.000163	0.000247	CcSEcCtD
Ganciclovir—Body temperature increased—Epirubicin—testicular cancer	0.000163	0.000247	CcSEcCtD
Ganciclovir—Hypersensitivity—Methotrexate—testicular cancer	0.000162	0.000246	CcSEcCtD
Ganciclovir—Asthenia—Methotrexate—testicular cancer	0.000158	0.00024	CcSEcCtD
Ganciclovir—Feeling abnormal—Doxorubicin—testicular cancer	0.000157	0.000239	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000156	0.000237	CcSEcCtD
Ganciclovir—Pruritus—Methotrexate—testicular cancer	0.000156	0.000237	CcSEcCtD
Ganciclovir—Hypersensitivity—Epirubicin—testicular cancer	0.000152	0.00023	CcSEcCtD
Ganciclovir—Urticaria—Doxorubicin—testicular cancer	0.000151	0.00023	CcSEcCtD
Ganciclovir—Abdominal pain—Doxorubicin—testicular cancer	0.00015	0.000229	CcSEcCtD
Ganciclovir—Body temperature increased—Doxorubicin—testicular cancer	0.00015	0.000229	CcSEcCtD
Ganciclovir—Diarrhoea—Methotrexate—testicular cancer	0.00015	0.000229	CcSEcCtD
Ganciclovir—Asthenia—Epirubicin—testicular cancer	0.000148	0.000224	CcSEcCtD
Ganciclovir—Pruritus—Epirubicin—testicular cancer	0.000146	0.000221	CcSEcCtD
Ganciclovir—Dizziness—Methotrexate—testicular cancer	0.000145	0.000221	CcSEcCtD
Ganciclovir—Diarrhoea—Epirubicin—testicular cancer	0.000141	0.000214	CcSEcCtD
Ganciclovir—Hypersensitivity—Doxorubicin—testicular cancer	0.00014	0.000213	CcSEcCtD
Ganciclovir—Vomiting—Methotrexate—testicular cancer	0.00014	0.000213	CcSEcCtD
Ganciclovir—Rash—Methotrexate—testicular cancer	0.000139	0.000211	CcSEcCtD
Ganciclovir—Dermatitis—Methotrexate—testicular cancer	0.000138	0.000211	CcSEcCtD
Ganciclovir—Headache—Methotrexate—testicular cancer	0.000138	0.000209	CcSEcCtD
Ganciclovir—Asthenia—Doxorubicin—testicular cancer	0.000137	0.000208	CcSEcCtD
Ganciclovir—Dizziness—Epirubicin—testicular cancer	0.000136	0.000207	CcSEcCtD
Ganciclovir—Pruritus—Doxorubicin—testicular cancer	0.000135	0.000205	CcSEcCtD
Ganciclovir—Vomiting—Epirubicin—testicular cancer	0.000131	0.000199	CcSEcCtD
Ganciclovir—Nausea—Methotrexate—testicular cancer	0.000131	0.000199	CcSEcCtD
Ganciclovir—Diarrhoea—Doxorubicin—testicular cancer	0.00013	0.000198	CcSEcCtD
Ganciclovir—Rash—Epirubicin—testicular cancer	0.00013	0.000197	CcSEcCtD
Ganciclovir—Dermatitis—Epirubicin—testicular cancer	0.00013	0.000197	CcSEcCtD
Ganciclovir—Headache—Epirubicin—testicular cancer	0.000129	0.000196	CcSEcCtD
Ganciclovir—Dizziness—Doxorubicin—testicular cancer	0.000126	0.000191	CcSEcCtD
Ganciclovir—Nausea—Epirubicin—testicular cancer	0.000122	0.000186	CcSEcCtD
Ganciclovir—Vomiting—Doxorubicin—testicular cancer	0.000121	0.000184	CcSEcCtD
Ganciclovir—Rash—Doxorubicin—testicular cancer	0.00012	0.000183	CcSEcCtD
Ganciclovir—Dermatitis—Doxorubicin—testicular cancer	0.00012	0.000182	CcSEcCtD
Ganciclovir—Headache—Doxorubicin—testicular cancer	0.000119	0.000181	CcSEcCtD
Ganciclovir—Nausea—Doxorubicin—testicular cancer	0.000113	0.000172	CcSEcCtD
